TLSI TriSalus Life Sciences, Inc. - Common Stock
NASDAQ · Biotechnology close Oct 2, 2026TLSI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
TLSI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.16 | $-0.16 | -1.2% |
| March 31, 2026 | May 12, 2026 | $0.03 | $-0.16 | 118.9% |
| Dec. 31, 2025 | $-0.21 | $-0.13 | -56.4% | |
| Sept. 30, 2025 | $-0.25 | $-0.15 | -65.0% | |
| June 30, 2025 | $-0.27 | $-0.22 | -21.1% | |
| March 31, 2025 | $-0.39 | $-0.22 | -73.8% |
Institutional owners (13F) 82 filers · $112.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-21 vs prior Q) | 14 (+4 vs prior Q) | 44 (+22 vs prior Q) | 10 (-4 vs prior Q) | +615K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| First Light Asset Management, LLC | $29,813,834 | 6,552,491 | 26.53% | Shares |
| BlackRock, Inc. | $12,099,442 | 2,659,218 | 10.77% | Shares |
| VANGUARD GROUP INC | $10,684,335 | 1,530,707 | 9.51% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $7,868,702 | 1,729,385 | 7.00% | Shares |
| Cerity Partners LLC | $7,296,098 | 1,603,538 | 6.49% | Shares |
| WASATCH ADVISORS LP | $5,751,840 | 1,437,960 | 5.12% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $5,416,203 | 1,190,067 | 4.82% | Shares |
| Nantahala Capital Management, LLC | $4,550,000 | 1,000,000 | 4.05% | Shares |
| GILDER GAGNON HOWE & CO LLC | $3,867,869 | 850,081 | 3.44% | Shares |
| STATE STREET CORP | $2,779,882 | 610,963 | 2.47% | Shares |
| WHITE PINE CAPITAL LLC | $2,491,475 | 547,577 | 2.22% | Shares |
| KENNEDY CAPITAL MANAGEMENT LLC | $2,166,988 | 476,261 | 1.93% | Shares |
| MORGAN STANLEY | $1,828,255 | 401,814 | 1.63% | Shares |
| NORTHERN TRUST CORP | $1,727,053 | 379,572 | 1.54% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,499,061 | 329,464 | 1.33% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,460,350 | 320,956 | 1.30% | Shares |
| PERKINS CAPITAL MANAGEMENT INC | $1,069,710 | 235,101 | 0.95% | Shares |
| UBS Group AG | $1,014,864 | 223,047 | 0.90% | Shares |
| KOTLER KEVIN | $1,013,496 | 145,200 | 0.90% | Shares |
| BANK OF AMERICA CORP /DE/ | $934,306 | 205,342 | 0.83% | Shares |
| ROYCE & ASSOCIATES LP | $910,273 | 200,060 | 0.81% | Shares |
| Corient Private Wealth LP | $669,542 | 147,152 | 0.60% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $536,797 | 117,977 | 0.48% | Shares |
| Bank of New York Mellon Corp | $507,478 | 111,534 | 0.45% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $491,150 | 107,945 | 0.44% | Shares |
| GOLDMAN SACHS GROUP INC | $374,911 | 82,398 | 0.33% | Shares |
| CWA Asset Management Group, LLC | $327,600 | 72,000 | 0.29% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $316,225 | 69,500 | 0.28% | Shares |
| Nuveen, LLC | $290,736 | 63,898 | 0.26% | Shares |
| Invesco Ltd. | $256,502 | 56,374 | 0.23% | Shares |
| DEUTSCHE BANK AG\ | $220,780 | 48,523 | 0.20% | Shares |
| HighMark Wealth Management LLC | $219,765 | 48,300 | 0.20% | Shares |
| WELLS FARGO & COMPANY/MN | $203,513 | 44,728 | 0.18% | Shares |
| MSD Partners, L.P. | $181,995 | 39,999 | 0.16% | Shares |
| SEI INVESTMENTS CO | $144,731 | 31,809 | 0.13% | Shares |
| MetLife Investment Management, LLC | $138,379 | 30,413 | 0.12% | Shares |
| RHUMBLINE ADVISERS | $137,043 | 30,121 | 0.12% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $109,923 | 24,159 | 0.10% | Shares |
| CITIGROUP INC | $102,443 | 22,515 | 0.09% | Shares |
| Connecticut Wealth Management, LLC | $101,479 | 22,303 | 0.09% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $100,432 | 22,073 | 0.09% | Shares |
| JPMORGAN CHASE & CO | $95,786 | 20,208 | 0.09% | Shares |
| Police & Firemen's Retirement System of New Jersey | $73,710 | 16,200 | 0.07% | Shares |
| Russell Investments Group, Ltd. | $70,256 | 15,441 | 0.06% | Shares |
| Vanguard Global Advisers, LLC | $69,469 | 15,268 | 0.06% | Shares |
| XTX Topco Ltd | $60,210 | 13,233 | 0.05% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $50,482 | 11,095 | 0.04% | Shares |
| INTECH INVESTMENT MANAGEMENT LLC | $47,707 | 10,485 | 0.04% | Shares |
| BARCLAYS PLC | $39,344 | 8,647 | 0.04% | Shares |
| CURA WEALTH ADVISORS, LLC | $35,600 | 10,000 | 0.03% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Frankenius Equity AB, Paul Frankenius ×4 filings | Aug. 4, 2025 | 14.00% | Amendment | · | SEC |
| Mats Wahlstrom, Kerry R. Hicks, HW Investment Partners, LLC ×2 filings | Aug. 1, 2025 | 6.00% | Amendment | · | SEC |
| Mats Wahlström, Kerry Hicks, HW Investment Partners, LLC | Aug. 21, 2023 | · | Initial filing | · | SEC |
| David J. Matlin | Aug. 21, 2023 | · | Initial filing | · | SEC |
| Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, David J. Snyderman ×5 filings | Aug. 14, 2023 | · | Initial filing | · | SEC |
| MedTech Acquisition Sponsor LLC, Christopher C. Dewey, David J. Matlin | July 6, 2023 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 23 insiders · 9 officers · 14 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Mary T Szela | CEO and President | May 15, 2026 P | 1,065,215 | 2 | 2 | $148,390 |
| Christopher C Dewey | Chief Executive Officer | Dec. 22, 2020 J | · | 0 | 0 | $0 |
| David Patience | Chief Financial Officer | May 15, 2026 P | 275,757 | 2 | 0 | $32,247 |
| James Emmett Young | Chief Financial Officer | May 19, 2025 A | 49,663 | 0 | 0 | $0 |
| Richard Marshak | Chief Commercial Officer | May 15, 2026 S | 125,101 | 0 | 4 | $-15,659 |
| Jodi Devlin | Chief of Clinical Operations | March 16, 2026 S | 97,364 | 0 | 3 | $-13,171 |
| Jennifer Stevens | Chief Regulatory Officer | March 16, 2026 S | 124,110 | 0 | 3 | $-14,510 |
| Bryan F. Cox | Chief of Research | March 16, 2026 S | 163,415 | 0 | 3 | $-13,085 |
| Steven C Katz | CHIEF MEDICAL OFFICER | Feb. 12, 2024 A | 68,587 | 0 | 0 | $0 |
| Gary B. Gordon | Director | May 15, 2026 P | 72,510 | 2 | 0 | $64,600 |
| Mats Wahlstrom | Director | May 15, 2026 P | 147,555 | 1 | 0 | $151,800 |
| Stansky Michael P | Director | May 15, 2026 P | 399,698 | 4 | 0 | $3,005,502 |
| William Valle | Director | May 14, 2026 A | 83,241 | 1 | 0 | $124,997 |
| David J Matlin | Director | May 14, 2026 A | 1,323,210 | 0 | 0 | $0 |
| Kerry R. Hicks | Director | May 14, 2026 A | 542,790 | 0 | 0 | $0 |
| Arjun Jj Desai | Director | June 12, 2025 A | 247,127 | 0 | 0 | $0 |
| Sean Murphy | Director | June 12, 2025 A | 123,989 | 0 | 0 | $0 |
| Liselotte Hyveled | Director | Jan. 2, 2025 A | 10,040 | 0 | 0 | $0 |
| George Kelly Martin | Director | Aug. 28, 2024 S | 247,176 | 0 | 0 | $0 |
| Anil K. Singhal | Director | Aug. 13, 2024 A | · | 0 | 0 | $0 |
| Andrew C. Von Eschenbach | Director | Aug. 13, 2024 A | · | 0 | 0 | $0 |
| Frankenius Equity AB | 10% owner | July 31, 2025 C | 6,989,748 | 0 | 0 | $0 |
| MedTech Acquisition Sponsor LLC | 10% owner | Dec. 22, 2020 J | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 10 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.45% | 24,220 SH | Oct. 1, 2026 | Daily |
| IWC · iShares Trust | 0.05% | 162,444 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 450,180 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 275,456 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 51,751 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 22,914 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 1,096,555 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 545,765 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,141,870 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,257 SH | Aug. 19, 2026 | Daily |
TLSI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
5 analysts · 2026-09-28Mean target $10.40 +140.7%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.